-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, K+ImVEJ8cRPfRQ/H+aJy1vhCvUQBuADHoQ+O+rqchQpg3Ze+8fD3cHOwOZrwNuwb vUSj1kZGYxI8lD4VJQkCbA== 0001140361-11-000555.txt : 20110104 0001140361-11-000555.hdr.sgml : 20110104 20110104135805 ACCESSION NUMBER: 0001140361-11-000555 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101231 FILED AS OF DATE: 20110104 DATE AS OF CHANGE: 20110104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASAR VINIT K CENTRAL INDEX KEY: 0001454324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 11504736 MAIL ADDRESS: STREET 1: HANGER ORTHOPEDIC GROUP, INC. STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0303 4 2010-12-31 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001454324 ASAR VINIT K 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 EVP & Chief Growth Officer Common Stock 2010-12-31 4 S 0 2850 21.568 D 40730 D The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. These shares were sold at a range of sale prices from $21.50 to $21.62. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares which total 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock made on March 30, 2010; and (ii) unvested restricted shares and fully vested shares that total 35,730 shares of stock from an initial grant of 42,680 shares of restricted stock and performance shares made on December 29, 2008. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Teri L. Champ, Attorney-in-Fact for Vinit K. Asar 2011-01-04 -----END PRIVACY-ENHANCED MESSAGE-----